Circulating PTH molecular forms: what we know and what we don't

Area of Science:

• Endocrinology
• Molecular Biology
• Bone Biology

Background:

• Circulating parathyroid hormone (PTH) comprises multiple molecular forms, including intact PTH(1-84) and various carboxyl-terminal (C-PTH) fragments.
• These fragments differ in their structure, abundance, and regulation by calcium (Ca).
• Previous research identified C-PTH fragments as significant components of circulating PTH, particularly in renal failure.

Purpose of the Study:

• To characterize the different circulating molecular forms of parathyroid hormone (PTH).
• To investigate the distinct biological effects and receptor interactions of PTH(1-84) and its C-terminal fragments.
• To elucidate the potential roles of these diverse PTH forms in calcium and bone metabolism.

Main Methods:

• Serum fractionation using gel chromatography and high-performance liquid chromatography.
• Immunoassays to detect and quantify different PTH molecular forms.
• Assessment of receptor binding and biological activity of synthetic PTH fragments.

Main Results:

• Circulating PTH includes PTH(1-84), N-truncated fragments (non-(1-84) PTH), and C-terminal fragments (C-PTH).
• C-PTH fragments, representing up to 95% of circulating PTH in renal failure, bind to a distinct C-PTH receptor and exert opposite effects on bone compared to PTH(1-84).
• N-truncated fragments show high affinity for the C-PTH receptor and are acutely regulated by calcium, potentially contributing significantly to biological effects.

Conclusions:

• PTH(1-84) and C-PTH fragments are differentially regulated and interact with distinct receptors, mediating opposing biological effects on bone.
• These diverse PTH forms and their signaling pathways offer a complex mechanism for fine-tuning bone turnover and calcium homeostasis.
• Further research is needed to fully understand the biological activity of a newly identified N-terminal PTH form and the precise roles of all PTH fragments in vivo.